The effects of COVID-19 on the vestibular system.
COVID-19
SVV
vHIT
vestibular system
vestibular-evoked myogenic potential (VEMP)
Journal
Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899
Informations de publication
Date de publication:
2023
2023
Historique:
received:
30
12
2022
accepted:
23
02
2023
entrez:
27
3
2023
pubmed:
28
3
2023
medline:
28
3
2023
Statut:
epublish
Résumé
The symptoms and severity of SARS-CoV-2 infection vary greatly across the spectrum, from asymptomatic infection to severe pneumonia with acute respiratory distress syndrome and even death. Dizziness is a frequently reported symptom of SARS-CoV-2 viral infection. However, the extent to which this symptom results from the effect of SARS-CoV-2 on the vestibular system remains unclear. In the present single-center, prospective cohort study, patients with a previous SARS-CoV-2 infection underwent a vestibular assessment consisting of the Dizziness Handicap Inventory to assess dizziness during and after infection, a clinical examination, the video head impulse test, and the subjective visual vertical test. When the subjective visual vertical test result was abnormal, vestibular-evoked myogenic potentials were performed. Vestibular testing results were compared to pre-existing normative data of healthy controls. In addition, we performed a retrospective data analysis of patients admitted to hospital presenting with acute symptoms of dizziness who were also diagnosed with acute SARS-CoV-2 infection. A total of 50 participants have been enrolled. During and after the SARS-CoV-2 infection, women were significantly more likely than men to suffer from dizziness. A significantly reduced semicircular canal or otolith function was not observed in either women or men. Acute SARS-CoV-2 infection was diagnosed in nine patients who presented to the emergency room with acute vestibular syndrome. Six of the patients exhibited acute unilateral peripheral vestibulopathy upon diagnosis. A different patient was diagnosed with vestibular migraine, and two individuals had a posterior inferior cerebellar artery infarct revealed by magnetic resonance imaging. Overall, a persisting structural affection of the vestibular system by SARS-CoV-2 seems to be unlikely and could not be confirmed by vHIT, SVV, and VEMPS in our study. It seems possible but unlikely that SARS-CoV-2 induces acute vestibulopathy. Nevertheless, dizziness is a common symptom in patients with COVID-19, which should be taken and worked through seriously.
Identifiants
pubmed: 36970515
doi: 10.3389/fneur.2023.1134540
pmc: PMC10036591
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1134540Informations de copyright
Copyright © 2023 Zaubitzer, Ludwig, Berkemann, Walter, Jungbauer, Held, Hegemann, Rotter and Schell.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Int J Audiol. 2021 Dec;60(12):935-945
pubmed: 33750252
Front Neurol. 2013 Mar 22;4:29
pubmed: 23526567
J Am Acad Audiol. 1991 Oct;2(4):253-60
pubmed: 1837740
Cureus. 2020 Jun 30;12(6):e8918
pubmed: 32760619
Otol Neurotol. 2021 Jan;42(1):e10-e14
pubmed: 33301283
J Clin Med. 2022 Jul 04;11(13):
pubmed: 35807167
J Neurol. 2018 May;265(5):1210-1218
pubmed: 29557501
Laryngorhinootologie. 2010 Jul;89(7):418-23
pubmed: 20440669
BMJ Case Rep. 2020 Oct 13;13(11):
pubmed: 33051251
Lancet Neurol. 2020 Nov;19(11):919-929
pubmed: 33031735
J Thromb Haemost. 2020 Apr;18(4):786-787
pubmed: 32212240
Int J Immunopathol Pharmacol. 2021 Jan-Dec;35:20587384211027373
pubmed: 34142589
J Clin Neurol. 2022 Mar;18(2):247-249
pubmed: 35274845
Eur J Neurol. 2022 Dec;29(12):3693-3700
pubmed: 36056895
Mayo Clin Proc. 2020 Aug;95(8):1801-1803
pubmed: 32753155
J Neurol Sci. 2020 Jul 15;414:116871
pubmed: 32422428
Am J Otolaryngol. 2015 Nov-Dec;36(6):823-7
pubmed: 26545480
Eur Arch Otorhinolaryngol. 2021 May;278(5):1675-1685
pubmed: 33011957
Arch Otolaryngol Head Neck Surg. 1990 Apr;116(4):424-7
pubmed: 2317323
Acta Otorhinolaryngol Ital. 2022 Apr;42(Suppl. 1):S87-S93
pubmed: 35763279
Audiol Neurootol. 2022;27(4):297-311
pubmed: 35240596
J Neurol. 2022 Feb;269(2):587-596
pubmed: 34386903
ACS Chem Neurosci. 2020 Apr 1;11(7):995-998
pubmed: 32167747
Int J Pediatr Otorhinolaryngol. 2023 Jan;164:111406
pubmed: 36521194
Am J Otolaryngol. 2022 Jan-Feb;43(1):103173
pubmed: 34392022
J Anxiety Disord. 2001 Jan-Apr;15(1-2):9-26
pubmed: 11388360
Blood. 2020 Jun 4;135(23):2033-2040
pubmed: 32339221
Neurol Sci. 2022 Aug;43(8):4635-4643
pubmed: 35608736
Neurology. 2009 Oct 6;73(14):1134-41
pubmed: 19805730
Brain Behav Immun. 2020 Jul;87:18-22
pubmed: 32240762
Am J Otolaryngol. 2020 May - Jun;41(3):102473
pubmed: 32276732
Crit Care. 2020 Jun 18;24(1):360
pubmed: 32552865
Int J Audiol. 2020 Jul;59(7):487-491
pubmed: 32530326
Front Neurol. 2022 Jul 01;13:917845
pubmed: 35847228
Otol Neurotol. 2021 Sep 1;42(8):e1072-e1076
pubmed: 34238895
Ann N Y Acad Sci. 1999 May 28;871:221-31
pubmed: 10372074
IDCases. 2021;24:e01131
pubmed: 33898251
Otol Neurotol. 2019 Jan;40(1):88-95
pubmed: 30289843
Ear Nose Throat J. 2021 Jan;100(1):29-30
pubmed: 32931322
JAMA Neurol. 2020 Jun 1;77(6):683-690
pubmed: 32275288
Bosn J Basic Med Sci. 2022 Feb 01;22(1):39-45
pubmed: 34392827
Cerebrovasc Dis. 2005;20(5):370-80
pubmed: 16205055